IMM 1.61% 31.5¢ immutep limited

before-you-plow-into-endocyte-inc..., page-5

  1. 193 Posts.
    And don't forget...if approved PRR has the ability to target other cancers beside ovarian....any muc-1 going by the reports......so PRR will be targetting a bigger market.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.